Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MiCo BioMed is a South Korean biotechnology company specializing in advanced diagnostic solutions through its proprietary Lab-on-a-Chip (LoC) technology. The company develops, manufactures, and markets a comprehensive range of molecular, biochemical, and immunodiagnostic products designed for rapid point-of-care testing (POCT). Its flagship Veri-Q platform provides high-speed PCR results for infectious diseases such as COVID-19, malaria, and tuberculosis, as well as chronic disease management for conditions like diabetes and anemia. By integrating microfluidics and MEMS technology, MiCo BioMed offers portable, lab-quality diagnostic tools for clinical, environmental, and food safety applications globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mi-Co.